Tower Research Capital (TRC)’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,340
| Closed | -$32.1K | – | 6038 |
|
|
2024
Q4 | $32.1K | Buy |
3,340
+148
| +5% | +$1.42K | ﹤0.01% | 2860 |
|
|
2024
Q3 | $9.13K | Sell |
3,192
-7,902
| -71% | -$22.6K | ﹤0.01% | 3902 |
|
|
2024
Q2 | $32.4K | Buy |
11,094
+4,403
| +66% | +$12.9K | ﹤0.01% | 3428 |
|
|
2024
Q1 | $21.3K | Sell |
6,691
-3,988
| -37% | -$12.7K | ﹤0.01% | 2942 |
|
|
2023
Q4 | $35.9K | Buy |
10,679
+5,606
| +111% | +$18.8K | ﹤0.01% | 3330 |
|
|
2023
Q3 | $12.1K | Sell |
5,073
-1,890
| -27% | -$4.5K | ﹤0.01% | 3929 |
|
|
2023
Q2 | $12.3K | Sell |
6,963
-9,828
| -59% | -$17.3K | ﹤0.01% | 3866 |
|
|
2023
Q1 | $51K | Buy |
16,791
+11,440
| +214% | +$34.7K | ﹤0.01% | 2485 |
|
|
2022
Q4 | $28K | Sell |
5,351
-2,105
| -28% | -$11K | ﹤0.01% | 2823 |
|
|
2022
Q3 | $26K | Sell |
7,456
-512
| -6% | -$1.79K | ﹤0.01% | 3734 |
|
|
2022
Q2 | $20K | Buy |
7,968
+4,958
| +165% | +$12.4K | ﹤0.01% | 3815 |
|
|
2022
Q1 | $13K | Buy |
3,010
+1,426
| +90% | +$6.16K | ﹤0.01% | 4012 |
|
|
2021
Q4 | $11K | Sell |
1,584
-270
| -15% | -$1.88K | ﹤0.01% | 4477 |
|
|
2021
Q3 | $13K | Sell |
1,854
-626
| -25% | -$4.39K | ﹤0.01% | 4111 |
|
|
2021
Q2 | $25K | Sell |
2,480
-620
| -20% | -$6.25K | ﹤0.01% | 3698 |
|
|
2021
Q1 | $30K | Sell |
3,100
-1,522
| -33% | -$14.7K | ﹤0.01% | 3573 |
|
|
2020
Q4 | $51K | Buy |
4,622
+2,176
| +89% | +$24K | ﹤0.01% | 3112 |
|
|
2020
Q3 | $22K | Buy |
+2,446
| New | +$22K | ﹤0.01% | 3837 |
|